TP53 and head and neck squamous cell carcinoma: Finally, we have shown that HNSCC patients with TP53 mutations and high levels of FOXM1 expression have poorer survival outcomes than those without one or both of these features, indicating the potential prognostic value of TP53 mutations and FOXM1 expression in HNSCC.